CT体成分表型对肝细胞癌切除术后男性患者复发的预后价值
多中心回顾性研究纳入497例肝细胞癌切除患者,利用CT分割脂肪与肌肉并提取L3层面体成分参数。在男性患者中,联合皮下脂肪指数与骨骼肌密度构建3种体成分表型,高危表型2年无复发生存率显著低于低危表型。体成分表型的风险分层价值优于单一体成分参数。
要点
- 男性患者中低皮下脂肪指数且低骨骼肌密度提示2年复发风险显著升高
- 体成分表型联合评估优于单独使用皮下脂肪指数或骨骼肌密度
- 可尝试在术前CT报告中对男性HCC患者标注L3层面体成分高危表型
核心结论
- 在肝细胞癌切除后的男性患者中,由皮下脂肪指数和骨骼肌密度构建的体成分表型对2年无复发生存率的分层价值优于单一体成分参数
- 高危表型(低皮下脂肪指数且低骨骼肌密度)的2年无复发生存率显著低于低危表型(HR:2.34;95% CI:1.36-4.03)
研究设计与样本
- 多中心回顾性研究,纳入5个医疗中心接受肝切除的肝细胞癌患者共497例
- 平均年龄59.3±11.0岁,男性396例,肝硬化患病率53.50%,中位随访38.1个月(95% CI:35.2-44.8个月)
- 采用TotalSegmentator在CT图像上分割脂肪和肌肉组织,并在L3层面进行人工校正以提取组织面积和CT密度参数
- 使用Cox比例风险模型识别影响2年无复发生存率的预后参数并构建体成分表型
关键影像表现/征象
- 体成分表型由皮下脂肪组织指数与骨骼肌密度联合定义,分为低危(高皮下脂肪指数且高骨骼肌密度)、高危(低皮下脂肪指数且低骨骼肌密度)和中间危三组
诊断标准与关键数值
- 男性患者中,低危表型定义为高皮下脂肪指数且高骨骼肌密度
- 男性患者中,高危表型定义为低皮下脂肪指数且低骨骼肌密度
- 男性患者中,中间危表型为不符合低危或高危定义的其余患者
- 高危表型相对于低危表型的2年无复发生存率HR为2.34(95% CI:1.36-4.03)
临床应用与阅片要点
- 对男性肝细胞癌术前CT可在L3层面关注皮下脂肪面积与骨骼肌密度,识别高危体成分表型
- 骨骼肌密度降低与皮下脂肪指数降低同时存在时,应在报告中提示复发风险升高可能
- 体成分表型评估需在L3层面完成分割与测量,必要时进行人工校正以保证准确性
局限性
- 回顾性研究设计可能存在选择偏倚
- 体成分表型的预后价值仅在男性患者中显示,女性患者未报告相应结果
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to explore the prognostic value of body composition (BC) parameters derived from CT imaging and their derived phenotypes following resection of hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Retrospective collection of HCC patients who underwent liver resection at 5 medical centers. TotalSegmentator was employed to segment adipose and muscle tissues on CT images. Manual corrections were performed at the L3 level to extract tissue area and CT density parameters. Cox proportional hazards models were used to identify potential prognostic parameters for 2-year recurrence-free survival (RFS) and construct BC phenotypes. Further exploration was conducted on the prognostic value of the BC phenotypes.
RESULTS: A total of 497 patients were included (mean age, 59.3 ± 11.0 years; 396 men; cirrhosis prevalence, 53.50%), with a median follow-up of 38.1 months [95% CI, 35.2-44.8 months]. Among male patients, combining the subcutaneous adipose tissue (SAT) index and skeletal muscle (SM) density identified 3 phenotypes with significant survival differences: low risk (high SAT index and high SM density), high risk (low SAT index and low SM density), and intermediate risk (the remaining patients). The high-risk phenotype had a significantly lower 2-year RFS than the low-risk phenotype (HR: 2.34; 95% CI, 1.36-4.03), exceeding the prognosis value of individual BC parameters.
CONCLUSION: BC phenotypes derived from SAT index and SM density provide superior risk stratification for 2-year RFS compared with individual BC parameters in male patients after HCC resection.
引用
- Zhang, Xia, Zhang, et al. Prognostic value of CT-derived body composition phenotypes for patients undergoing resection of hepatocellular carcinoma: a multicenter study. Abdom Radiol (NY). 2026. PMID: 42484848. doi:10.1007/s00261-026-05692-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。